JEFFERIES BROADVIEW ADVISES WUXI PHARMATECH

WuXi PharmaTech'S IPO prices at $14 per ADS

NEW YORK, Aug 8 (Reuters) - An initial public offering by WuXi PharmaTech (Cayman) Inc. priced at $14 per American Depositary Share, the company said on Wednesday. The offering was 13.2 million ADS. Credit Suisse, JPMorgan and Jefferies & Co. underwrote the offering of the China-based pharmaceutical and biotechnology research and development outsourcing company.